SomaLogic, Inc. (SLGC)

NASDAQ: SLGC · IEX Real-Time Price · USD
3.07
+0.17 (5.86%)
Oct 3, 2022 4:00 PM EDT - Market closed
5.86%
Market Cap 563.20M
Revenue (ttm) 80.11M
Net Income (ttm) -91.69M
Shares Out 183.45M
EPS (ttm) -0.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,523,108
Open 2.98
Previous Close 2.90
Day's Range 2.84 - 3.14
52-Week Range 2.84 - 14.72
Beta n/a
Analysts Buy
Price Target 7.91 (+157.7%)
Earnings Date Nov 14, 2022

About SLGC

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein... [Read more...]

Industry Health Information Services
Founded 2000
Employees 320
Stock Exchange NASDAQ
Ticker Symbol SLGC
Full Company Profile

Financial Performance

In 2021, SomaLogic's revenue was $81.63 million, an increase of 46.05% compared to the previous year's $55.89 million. Losses were -$87.55 million, 65.1% more than in 2020.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for SLGC stock is "Buy." The 12-month stock price forecast is 7.91, which is an increase of 157.65% from the latest price.

Price Target
$7.91
(157.65% upside)
Analyst Consensus: Buy
Stock Forecasts

News

SomaLogic's Chief Medical Officer Steve Williams honored with C-Suite Award by the Denver Business Journal

BOULDER, Colo., Sept. 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced that Chief Medical Officer Steve Williams, M.D., Ph.D., has...

1 week ago - GlobeNewsWire

SomaLogic to Present at the Capital One Spatial Biology & Proteomics Summit

BOULDER, Colo., Sept. 14, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that management will be participating in the upcoming Capital One Sp...

2 weeks ago - GlobeNewsWire

SomaLogic, Inc. (SLGC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

SomaLogic, Inc. (SLGC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean...

1 month ago - Zacks Investment Research

SomaLogic to Present at Morgan Stanley 20th Annual Global Healthcare Conference

BOULDER, Colo., Aug. 31, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming Morgan Stanley...

1 month ago - GlobeNewsWire

SomaLogic Reports Second Quarter 2022 Financial Results

BOULDER, Colo., Aug. 15, 2022 (GLOBE NEWSWIRE) --  SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the quarter ended June 30, 2022.

1 month ago - GlobeNewsWire

SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay

BOULDER, Colo. and SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire Palame...

2 months ago - GlobeNewsWire

SomaLogic to Announce Second Quarter 2022 Financial Results

BOULDER, Colo. , July 25, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the second quarter 2022 af...

2 months ago - GlobeNewsWire

SomaLogic to Announce First Quarter 2022 Financial Results

BOULDER, Colo., April 21, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the first quarter 2022 aft...

5 months ago - GlobeNewsWire

Major journal publishes landmark proteomics study demonstrating development of an unprecedented new clinical cardiova...

SomaScan® platform study utilizing 32,000 samples showed a 27-protein test is a uniquely superior surrogate for cardiovascular outcomes SomaScan® platform study utilizing 32,000 samples showed a 27-prot...

5 months ago - GlobeNewsWire

Know The 2 Healthcare Companies Cathie Wood's Ark Invest Bought On Friday

Cathie Wood's Ark Invest may have had a disappointing 2021, but the fund's purchases/liquidations are always watched keenly by investors. On Friday, ETFs managed by Ark Invest picked up chunks of shares...

Other symbols: TWST
6 months ago - Benzinga

SomaLogic Reports Fourth Quarter and Full Year 2021 Financial Results

BOULDER, Colo., March 29, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the quarter and year ended December 31, 2021.

6 months ago - GlobeNewsWire

SomaLogic to Announce Fourth Quarter and Full Year 2021 Financial Results

BOULDER, Colo., March 01, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the fourth quarter and ful...

7 months ago - GlobeNewsWire

SomaLogic to Participate in the Cowen 42nd Annual Health Care Conference

BOULDER, Colo., Feb. 25, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the Cowen 42nd Annual Healt...

7 months ago - GlobeNewsWire

Why Earnings Season Could Be Great for SomaLogic (SLGC)

SomaLogic (SLGC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

7 months ago - Zacks Investment Research

SomaLogic Provides 2022 Revenue Guidance in Conjunction with Analyst and Investor Meeting

BOULDER, Colo., Feb. 04, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, will host a virtual analyst and investor meeting today, February 4th, 2022, from 10:0...

7 months ago - GlobeNewsWire

SomaLogic to Participate in Upcoming Investor Conferences

BOULDER, Colo., Feb. 02, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the following virtual inves...

8 months ago - GlobeNewsWire

SomaLogic to provide 105 million protein measurements from 15,000 samples as part of the Multi-Ethnic Study of Athero...

Data will be available to researchers studying a wide range of disease states Data will be available to researchers studying a wide range of disease states

8 months ago - GlobeNewsWire

SomaLogic Announces Appointment of Adam Taich as Chief Business Officer

BOULDER, Colo., Jan. 10, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Adam Taich has joined the company as the Chief Business Of...

8 months ago - GlobeNewsWire

Illumina (ILMN)-SomaLogic Ink Deal to Advance Proteomics

Illumina's (ILMN) collaboration with SomaLogic will boost the fast-growing high throughput sector of the proteomics market to aid research in biology and disease.

Other symbols: ILMN
8 months ago - Zacks Investment Research

SomaLogic, Graphite Bio Make List of Most Promising Life Sciences Companies

Two public companies made the BioSpace list of the 30 most promising North American life sciences startups. SomaLogic Inc. ( SLGC , Financial) and Graphite Bio Inc. ( GRPH , Financial) are included in t...

Other symbols: GRPH
8 months ago - GuruFocus

SomaLogic announces exclusive partnership with Illumina to develop sequencing-based proteomic solutions

Co-developed and co-branded products to combine market-leading proteomic and genomic analysis platforms Co-developed and co-branded products to combine market-leading proteomic and genomic analysis plat...

8 months ago - GlobeNewsWire

SomaLogic to Participate in the 40th Annual J.P. Morgan Healthcare Conference

BOULDER, Colo., Dec. 30, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming 40th Annual J....

9 months ago - GlobeNewsWire

SomaLogic Announces Appointment of Steven Mermelstein as Senior Vice President of Corporate Strategy, Development and...

BOULDER, Colo., Dec. 02, 2021 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Steve Mermelstein joined the company as Senior Vice Presid...

10 months ago - GlobeNewsWire

SomaLogic Reports Third Quarter 2021 Financial Results

BOULDER, Colo., Nov. 15, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the quarter ended September 30, 2021.

10 months ago - GlobeNewsWire

SomaLogic to Present at the Stifel 2021 Virtual Healthcare Conference

NEW YORK and BOULDER, Colo., Nov. 03, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming S...

11 months ago - GlobeNewsWire